Berger Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.02M Sell
6,540
-28
-0.4% -$28.4K 0.34% 69
2025
Q4
$7.06M Sell
6,568
-195
-3% -$186K 0.41% 54
2025
Q3
$5.16M Buy
6,763
+51
+0.8% +$38K 0.31% 76
2025
Q2
$5.23M Buy
6,712
+169
+3% +$131K 0.34% 77
2025
Q1
$5.4M Sell
6,543
-1
-0% -$832 0.38% 68
2024
Q4
$5.05M Buy
6,544
+803
+14% +$665K 0.35% 73
2024
Q3
$5.09M Buy
5,741
+2,841
+98% +$2.55M 0.37% 72
2024
Q2
$2.63M Buy
2,900
+44
+2% +$35.2K 0.21% 100
2024
Q1
$2.22M Buy
2,856
+104
+4% +$74K 0.18% 113
2023
Q4
$1.6M Sell
2,752
-37
-1% -$21.6K 0.17% 105
2023
Q3
$1.5M Buy
2,789
+14
+0.5% +$7.21K 0.17% 105
2023
Q2
$1.3M Sell
2,775
-82
-3% -$34.4K 0.15% 107
2023
Q1
$981K Buy
2,857
+453
+19% +$153K 0.12% 109
2022
Q4
$880K Buy
2,404
+371
+18% +$132K 0.12% 110
2022
Q3
$657K Buy
2,033
+594
+41% +$188K 0.1% 123
2022
Q2
$467K Buy
1,439
+40
+3% +$12K 0.07% 146
2022
Q1
$401K Sell
1,399
-159
-10% -$40.9K 0.05% 169
2021
Q4
$430K Buy
1,558
+153
+11% +$38.8K 0.06% 166
2021
Q3
$325K Buy
1,405
+195
+16% +$48.1K 0.06% 152
2021
Q2
$278K Sell
1,210
-214
-15% -$43K 0.05% 164
2021
Q1
$266K Buy
1,424
+62
+5% +$12.1K 0.06% 157
2020
Q4
$230K Buy
+1,362
New +$203K 0.04% 187

Other funds holding LLY

Berger Financial Group's LLY Position: Q1 2026 in Review

Berger Financial Group reduced its Eli Lilly (LLY) stake by 0.43% in Q1 2026, selling an estimated $28.4K and leaving 6,540 shares worth $6.02M. The position accounts for 0.34% of the portfolio, ranked #69.

Berger Financial Group first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. The position peaked at $7.06M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Berger Financial Group held 6,540 shares of Eli Lilly worth $6.02M as of Q1 2026.
  • Berger Financial Group sold 28 Eli Lilly shares in Q1 2026, an estimated $28.4K.
  • Eli Lilly made up 0.34% of Berger Financial Group's portfolio in Q1 2026, its #69 holding.
  • Berger Financial Group first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
  • Berger Financial Group's Eli Lilly position peaked at $7.06M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Berger Financial Group's 13F filing for Q1 2026, filed 28 Apr 2026.